Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Fatigue Phase 2 ClinicalTrials
Hemorrhage; Subarachnoid Hemorrhage Phase 2/Phase 3 ClinicalTrials
CONTENTS